Topher Brooke is a biopharmaceutical executive with over 25 years of experience leading venture-backed and public companies. As CEO of MasterSwitch Bio, he advances pioneer mRNA therapeutics. He previously served as COO for SwanBio Therapeutics and Aytu BioPharm, demonstrating a track record of building and exiting companies and advancing first-in-class therapies.
He serves on the Board of Advisors for Life Science Cares Philadelphia, an organization with a mission to disrupt the cycle of poverty and inequality in local communities. This role reflects his commitment to ensuring access to basic needs, education, and opportunity for everyone.
His current company, MasterSwitch Bio, was co-founded by 2023 Nobel Prize winner Dr. Drew Weissman to reverse end-stage liver disease.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.